Nitroimidazoles, including metronidazole and tinidazole, have been used in multiple antimicrobial therapy strategies to eradicate Helicobacterpylori in peptic ulcer patients and nonulcer dyspeptic patients (1, 19). However, emergence of primary resistance and acquired resistance to these kind of drugs in H. pyloni may lead to treatment failure (3, 7, 10, 11, 21, 27 ). Thus, evaluation of H. pylotn susceptibility to metronidazole before treatment appears to be important. Metronidazole resistance rates from 6.4 to 84% have been reported throughout the world (2, 11, 13, 22 
Furthermore, 76 H. pylon-positive patients with duodenal ulcers or nonulcer dyspepsia were treated with a 1 week of triple therapy (colloidal bismuth subcitrate, metronidazole, and tetracycline). H. pylori strains were isolated before treatment from antral biopsies from those patients, and the metronidazole susceptibilities of the strains were determined by the disk diffusion test. H. pylorz status was evaluated again 4 weeks after completion of treatment. The eradication rates for susceptible, intermediate, and resistant strains were 95.9% (47 of 49), 62.5% (5 of 8), and 52.6% (10 of 19), respectively. It is concluded that the 5-g,g disk diffusion test is easy to perform and gives final results similar to those of the plate dilution method. The three interpretive categories of susceptibility may be of benefit for clinical choice of chemotherapy in eradicating H. pylon.
Nitroimidazoles, including metronidazole and tinidazole, have been used in multiple antimicrobial therapy strategies to eradicate Helicobacterpylori in peptic ulcer patients and nonulcer dyspeptic patients (1, 19) . However, emergence of primary resistance and acquired resistance to these kind of drugs in H. pyloni may lead to treatment failure (3, 7, 10, 11, 21, 27 ). Thus, evaluation of H. pylotn susceptibility to metronidazole before treatment appears to be important. Metronidazole resistance rates from 6.4 to 84% have been reported throughout the world (2, 11, 13, 22) . In Ireland, 27.5% of pretreatment strains of H. pylon were resistant to metronidazole (26) . In other European countries, the resistance rate varied from 7 to 49% (8) . The difference in the rates reported may reflect the variation in metronidazole usage between countries, since use of metronidazole alone can easily induce resistance to the drug in H. pyloni (11, 14, 24 A MIC of 8 ,ug/ml has been used in previous studies as a breakpoint to differentiate susceptible and resistant strains (11, 13, 18, 27) . In the present study, three interpretive categories were defined; strains with metronidazole MICs of less than 4 ,ug/ml were defined as susceptible, strains with metronidazole MICs between 4 and 8 ,ug/ml were defined as intermediate, and those with metronidazole MICs of greater than 8 ,ug/ml were deemed resistant, since strains with metronidazole MICs between 4 and 8 ,ug/ml can be more easily selected to become metronidazole resistant (24 Fig. 1 (Fig. 2) . However, the false-susceptibility rate was 0% (0 of 24) and the false-resistance rate was 2.3% (2 of 88). Results obtained after incubation for 3 days showed a slightly higher interpretive error rate of 14.9% (18 of 121) and a falseresistance rate of 3.4% (3 of 88), while data obtained after incubation for 5 (12) . In the present study, the activity of metronidazole against H. pylon exhibited a bimodal phenomenon, suggesting that clinical strains of H. pylon are either highly susceptible to metronidazole or highly resistant to this drug. Since the strains tested in this study were nonselected, the findings obtained may also reflect the natural distribution of MICs of metronidazole against H. pylori in the general population.
Five methods have been applied in the testing of H. pylori susceptibility to metronidazole. The plate dilution method, which has been considered a standard susceptibility testing method (12), is not always a practical method in a routine laboratory; e.g., it is not applicable to individual strains. Its accuracy and precision have been reported to be worse than those of the E test and the disk test (15) . The microdilution broth method is not practical because of the difficulty in growing H. pylon in liquid media and the potential for contamination (7, 12, 20) . The breakpoint method is very simple (11) , but the results are less precise and accurate and are not satisfactory when three interpretive categories are required. The E test, which was developed in 1988 (5) and found to be as easy to perform as the disk diffusion method and to give MIC results comparable to those of the agar dilution method (6, (14, 16) . Moreover, the low levels of false susceptibility (0%) and false resistance (2.3%) confirm the suitability of the disk diffusion test.
It is generally accepted that strains of H. pylorz with metronidazole MICs of more than 8 iLg/ml are resistant to metronidazole (11, 13, 18, 27) . However, there are no generally accepted criteria for the inhibitory zone size that differentiates susceptible and resistant strains in the disk diffusion test, although several studies have used this technique (4, 7, 9, 12, 13, (15) (16) (17) 22) . Disks with different amounts of metronidazole have been used. Culture media and incubation times have also varied from laboratory to laboratory. In our experience, a 5-,ug disk can give good discrimination between susceptible and resistant strains, so it was used in this study to establish an interpretive zone diameter standard for susceptibility to metronidazole. Three interpretive categories of susceptibility were introduced in the present study. Since it has been found that strains with metronidazole MICs between 4 and 8 ,ug/ml could easily develop resistance to metronidazole in vitro (24) , it was recommended that strains with metronidazole MICs of less than 4 In vitro synergistic activities between metronidazole, tetracycline, and bismuth salt have been observed (20, 23, 25) . In the present study, the clinical efficacy of 1 week of triple therapy including these drugs was evaluated. The eradication rates were 91.2% for susceptible strains and 52.6% for resistant strains. With the three interpretive categories used, the eradication rates for susceptible, intermediate, and resistant strains were 95.9, 62.5, and 52.6%, respectively. It has been observed that once treatment fails, emergence of metronidazole resistance in the organism is almost inevitable (3, 27) . In the present study, only 4.1% of susceptible strains were not eradicated while the rate of noneradication of intermediate strains was 37.5%; all of these became metronidazole resistant. This also confirms a previous study which showed that strains with metronidazole MICs between 4 and 8 ,g/ml can easily develop resistance (24) .
The findings in the present study indicate that pretreatment resistance and acquired metronidazole resistance might be the only factors leading to treatment failure when good compliance is achieved, despite an over 50% eradication rate for resistant strains with triple therapy. Thus, testing of H. pylori susceptibility to metronidazole and interpretation of the results before commencing antimicrobial therapy are still important. The disk diffusion test is easy to perform and gives accurate and precise results. Three interpretive categories of susceptibility may be of benefit for clinical choice of chemotherapy in eradicating H. pylori. When the strain is susceptible to metronidazole, there is little doubt that metronidazole is the first drug to be used; when the strain is intermediate, either metronidazole should be avoided or high doses should be used; when the strain is resistant, metronidazole should be replaced by other antimicrobial agents.
